The management of Sjögren's syndrome in dental practice.
Identifieur interne : 000501 ( Main/Exploration ); précédent : 000500; suivant : 000502The management of Sjögren's syndrome in dental practice.
Auteurs : I. Al-Hashimi [États-Unis]Source :
- Journal of the American Dental Association (1939) [ 0002-8177 ] ; 2001.
Descripteurs français
- KwdFr :
- Candidose (traitement médicamenteux), Caries dentaires (prévention et contrôle), Consommation de boisson (MeSH), Humains (MeSH), Salive (métabolisme), Salive artificielle (usage thérapeutique), Soins dentaires pour malades chroniques (MeSH), Syndrome de Gougerot-Sjögren (complications), Syndrome de Gougerot-Sjögren (thérapie), Xérophtalmie (étiologie), Xérostomie (MeSH).
- MESH :
- métabolisme : Salive.
- prévention et contrôle : Caries dentaires.
- thérapie : Syndrome de Gougerot-Sjögren.
- traitement médicamenteux : Candidose.
- usage thérapeutique : Salive artificielle, Syndrome de Gougerot-Sjögren.
- étiologie : Xérophtalmie.
- Consommation de boisson, Humains, Soins dentaires pour malades chroniques, Xérostomie.
English descriptors
- KwdEn :
- Candidiasis (drug therapy), Dental Care for Chronically Ill (MeSH), Dental Caries (prevention & control), Drinking (MeSH), Humans (MeSH), Saliva (metabolism), Saliva, Artificial (therapeutic use), Sjogren's Syndrome (complications), Sjogren's Syndrome (therapy), Xerophthalmia (etiology), Xerostomia (MeSH).
- MESH :
- chemical , therapeutic use : Saliva, Artificial.
- complications : Sjogren's Syndrome.
- drug therapy : Candidiasis.
- etiology : Xerophthalmia.
- metabolism : Saliva.
- prevention & control : Dental Caries.
- therapy : Sjogren's Syndrome.
- Dental Care for Chronically Ill, Drinking, Humans, Xerostomia.
Abstract
BACKGROUND
Sjögren's syndrome, or SS, is a multisystem inflammatory disorder of the exocrine glands with a wide range of extraglandular involvement. Symptoms of dry eyes and xerostomia, although not invariably present, are characteristic features of SS. An increased risk of oral and dental diseases is a prominent consequence of SS.
TYPES OF STUDIES REVIEWED
The author reviewed recent medical and dental studies that have advanced our understanding of the causes and treatment of SS. She particularly focused on studies addressing the diagnosis and treatment of the oral component of the disease.
RESULTS
Sjögren's syndrome is a widely underdiagnosed disease. A delay in the diagnosis of SS may have a significant physical, psychological and economic impact on the affected person. The pathogenesis of SS appears to involve a number of factors: immunological, genetic, hormonal and possibly infectious. Successful management of SS requires a multidisciplinary approach, and the dentist plays an essential role in the diagnosis and treatment of the disease. ORAL IMPLICATIONS: Impairment of salivary function in SS increases the risk of developing oral diseases. Effective management of oral health comprises enhancement of salivary output (cholinergic agonist drugs such as pilocarpine or cevimeline) and prevention and treatment of dental caries, oral candidiasis and allergic mucositis. Finally, periodic evaluation of various clinical and laboratory parameters is needed to monitor disease status.
DOI: 10.14219/jada.archive.2001.0056
PubMed: 11680356
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The management of Sjögren's syndrome in dental practice.</title><author><name sortKey="Al Hashimi, I" sort="Al Hashimi, I" uniqKey="Al Hashimi I" first="I" last="Al-Hashimi">I. Al-Hashimi</name><affiliation wicri:level="1"><nlm:affiliation>Salivary Dysfunction Clinic, Baylor College of Dentistry, Department of Periodontology, 3302 Gastom Ave., Dallas, Texas 75246, USA. alhashim@ont.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Salivary Dysfunction Clinic, Baylor College of Dentistry, Department of Periodontology, 3302 Gastom Ave., Dallas, Texas 75246</wicri:regionArea><wicri:noRegion>Texas 75246</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11680356</idno><idno type="pmid">11680356</idno><idno type="doi">10.14219/jada.archive.2001.0056</idno><idno type="wicri:Area/Main/Corpus">000512</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000512</idno><idno type="wicri:Area/Main/Curation">000512</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000512</idno><idno type="wicri:Area/Main/Exploration">000512</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The management of Sjögren's syndrome in dental practice.</title><author><name sortKey="Al Hashimi, I" sort="Al Hashimi, I" uniqKey="Al Hashimi I" first="I" last="Al-Hashimi">I. Al-Hashimi</name><affiliation wicri:level="1"><nlm:affiliation>Salivary Dysfunction Clinic, Baylor College of Dentistry, Department of Periodontology, 3302 Gastom Ave., Dallas, Texas 75246, USA. alhashim@ont.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Salivary Dysfunction Clinic, Baylor College of Dentistry, Department of Periodontology, 3302 Gastom Ave., Dallas, Texas 75246</wicri:regionArea><wicri:noRegion>Texas 75246</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of the American Dental Association (1939)</title><idno type="ISSN">0002-8177</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Candidiasis (drug therapy)</term><term>Dental Care for Chronically Ill (MeSH)</term><term>Dental Caries (prevention & control)</term><term>Drinking (MeSH)</term><term>Humans (MeSH)</term><term>Saliva (metabolism)</term><term>Saliva, Artificial (therapeutic use)</term><term>Sjogren's Syndrome (complications)</term><term>Sjogren's Syndrome (therapy)</term><term>Xerophthalmia (etiology)</term><term>Xerostomia (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Candidose (traitement médicamenteux)</term><term>Caries dentaires (prévention et contrôle)</term><term>Consommation de boisson (MeSH)</term><term>Humains (MeSH)</term><term>Salive (métabolisme)</term><term>Salive artificielle (usage thérapeutique)</term><term>Soins dentaires pour malades chroniques (MeSH)</term><term>Syndrome de Gougerot-Sjögren (complications)</term><term>Syndrome de Gougerot-Sjögren (thérapie)</term><term>Xérophtalmie (étiologie)</term><term>Xérostomie (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Saliva, Artificial</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Sjogren's Syndrome</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Candidiasis</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Xerophthalmia</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Saliva</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Salive</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Dental Caries</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Caries dentaires</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Sjogren's Syndrome</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Syndrome de Gougerot-Sjögren</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Candidose</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Salive artificielle</term><term>Syndrome de Gougerot-Sjögren</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Xérophtalmie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Dental Care for Chronically Ill</term><term>Drinking</term><term>Humans</term><term>Xerostomia</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Consommation de boisson</term><term>Humains</term><term>Soins dentaires pour malades chroniques</term><term>Xérostomie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Sjögren's syndrome, or SS, is a multisystem inflammatory disorder of the exocrine glands with a wide range of extraglandular involvement. Symptoms of dry eyes and xerostomia, although not invariably present, are characteristic features of SS. An increased risk of oral and dental diseases is a prominent consequence of SS.</p></div><div type="abstract" xml:lang="en"><p><b>TYPES OF STUDIES REVIEWED</b></p><p>The author reviewed recent medical and dental studies that have advanced our understanding of the causes and treatment of SS. She particularly focused on studies addressing the diagnosis and treatment of the oral component of the disease.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Sjögren's syndrome is a widely underdiagnosed disease. A delay in the diagnosis of SS may have a significant physical, psychological and economic impact on the affected person. The pathogenesis of SS appears to involve a number of factors: immunological, genetic, hormonal and possibly infectious. Successful management of SS requires a multidisciplinary approach, and the dentist plays an essential role in the diagnosis and treatment of the disease. ORAL IMPLICATIONS: Impairment of salivary function in SS increases the risk of developing oral diseases. Effective management of oral health comprises enhancement of salivary output (cholinergic agonist drugs such as pilocarpine or cevimeline) and prevention and treatment of dental caries, oral candidiasis and allergic mucositis. Finally, periodic evaluation of various clinical and laboratory parameters is needed to monitor disease status.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11680356</PMID><DateCompleted><Year>2001</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-8177</ISSN><JournalIssue CitedMedium="Print"><Volume>132</Volume><Issue>10</Issue><PubDate><Year>2001</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of the American Dental Association (1939)</Title><ISOAbbreviation>J Am Dent Assoc</ISOAbbreviation></Journal><ArticleTitle>The management of Sjögren's syndrome in dental practice.</ArticleTitle><Pagination><MedlinePgn>1409-17; quiz 1460-1</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sjögren's syndrome, or SS, is a multisystem inflammatory disorder of the exocrine glands with a wide range of extraglandular involvement. Symptoms of dry eyes and xerostomia, although not invariably present, are characteristic features of SS. An increased risk of oral and dental diseases is a prominent consequence of SS.</AbstractText><AbstractText Label="TYPES OF STUDIES REVIEWED" NlmCategory="METHODS">The author reviewed recent medical and dental studies that have advanced our understanding of the causes and treatment of SS. She particularly focused on studies addressing the diagnosis and treatment of the oral component of the disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sjögren's syndrome is a widely underdiagnosed disease. A delay in the diagnosis of SS may have a significant physical, psychological and economic impact on the affected person. The pathogenesis of SS appears to involve a number of factors: immunological, genetic, hormonal and possibly infectious. Successful management of SS requires a multidisciplinary approach, and the dentist plays an essential role in the diagnosis and treatment of the disease. ORAL IMPLICATIONS: Impairment of salivary function in SS increases the risk of developing oral diseases. Effective management of oral health comprises enhancement of salivary output (cholinergic agonist drugs such as pilocarpine or cevimeline) and prevention and treatment of dental caries, oral candidiasis and allergic mucositis. Finally, periodic evaluation of various clinical and laboratory parameters is needed to monitor disease status.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>al-Hashimi</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Salivary Dysfunction Clinic, Baylor College of Dentistry, Department of Periodontology, 3302 Gastom Ave., Dallas, Texas 75246, USA. alhashim@ont.com</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Dent Assoc</MedlineTA><NlmUniqueID>7503060</NlmUniqueID><ISSNLinking>0002-8177</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012464">Saliva, Artificial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002177" MajorTopicYN="N">Candidiasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017742" MajorTopicYN="Y">Dental Care for Chronically Ill</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003731" MajorTopicYN="N">Dental Caries</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004326" MajorTopicYN="N">Drinking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012464" MajorTopicYN="N">Saliva, Artificial</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="N">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014985" MajorTopicYN="N">Xerophthalmia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014987" MajorTopicYN="N">Xerostomia</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>65</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>10</Month><Day>30</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>1</Month><Day>5</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>10</Month><Day>30</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11680356</ArticleId><ArticleId IdType="pii">S0002-8177(14)63723-5</ArticleId><ArticleId IdType="doi">10.14219/jada.archive.2001.0056</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Al Hashimi, I" sort="Al Hashimi, I" uniqKey="Al Hashimi I" first="I" last="Al-Hashimi">I. Al-Hashimi</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000501 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000501 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:11680356
|texte= The management of Sjögren's syndrome in dental practice.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:11680356" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |